Parlodel and Abdominal pain - a phase IV clinical study of FDA data

Summary:

Abdominal pain is reported as a side effect among people who take Parlodel (bromocriptine mesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Meticorten, and have Acromegaly.

The phase IV clinical study analyzes which people have Abdominal pain when taking Parlodel. It is created by eHealthMe based on reports of 2,284 people who have side effects when taking Parlodel from the FDA, and is updated regularly.

What is Parlodel?

Parlodel has active ingredients of bromocriptine mesylate. eHealthMe is studying from 2,327 Parlodel users. Check the latest studies of Parlodel.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,226 drugs and 5,746 conditions by eHealthMe. Check the latest studies of Abdominal pain.

On Jul, 15, 2026

2,284 people reported to have side effects when taking Parlodel.
Among them, 42 people (1.84%) have Abdominal pain.

Among these 42 people:

How long have people been on Parlodel when they have Abdominal pain? *

What is the gender of people who have Abdominal pain when taking Parlodel? *

female: 100 %
male: 0.0 %

What is the age of people who have Abdominal pain when taking Parlodel? *

What are other drugs people take besides Parlodel? *

What are other side effects people have besides Abdominal pain? *

Headache (pain in head): 21 people, 50.00%
Fall: 18 people, 42.86%
Weight Increased: 17 people, 40.48%
Fatigue (feeling of tiredness): 17 people, 40.48%
Acute Upper Airway Obstruction (blockage occurs in the upper airway): 17 people, 40.48%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 17 people, 40.48%
Femur Fracture: 17 people, 40.48%
Malaise (a feeling of general discomfort or uneasiness): 16 people, 38.10%
Muscle Twitching: 16 people, 38.10%
Thyroid Diseases: 16 people, 38.10%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 17 people, 40.48%
Thyroid Diseases: 11 people, 26.19%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 9 people, 21.43%
Memory Loss: 5 people, 11.90%
Pituitary Tumor Benign: 3 people, 7.14%
Constipation: 2 people, 4.76%
Pain: 2 people, 4.76%
Osteoporosis (bones weak and more likely to break): 2 people, 4.76%
Nausea (feeling of having an urge to vomit): 2 people, 4.76%
Infertility: 2 people, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Parlodel and have Abdominal pain?

- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Parlodel:

Parlodel (2,327 reports)

Abdominal pain treatments and more:

Abdominal pain (286,410 reports)

Browse all side effects of Parlodel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain:

Abdominal pain (3,226 drugs)

Browse all the conditions that are associated with Abdominal pain:

Abdominal pain (5,746 conditions)

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on bromocriptine mesylate (the active ingredients of Parlodel) and Parlodel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.